Similar biological effect of high-dose oral versus intravenous methylprednisolone in multiple sclerosis relapses.
Grau-López L, Teniente-Serra A, Tintoré M, Rovira A, Ramió-Torrenta L, Brieva L, Saiz A, Cano A, Carmona O, Hervás JV, Martínez-Cáceres EM, Ramo-Tello C.
Grau-López L, et al. Among authors: tintore m.
Mult Scler. 2015 Apr;21(5):646-50. doi: 10.1177/1352458514546786. Epub 2014 Aug 21.
Mult Scler. 2015.
PMID: 25145693
Clinical Trial.